AbbVie
ABBV
#28
Rank
$279.17 B
Marketcap
$158.25
Share price
0.45%
Change (1 day)
-2.30%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2022 (TTM): $6.69

According to AbbVie's latest financial reports the company's current EPS (TTM) is $6.69. an increase over its 2021 EPS that were of $6.53.

EPS history for AbbVie from 2013 to 2022

Annual EPS

Year EPS Change
2022$6.611.19%
2021$6.53121.58%
2020$2.95-44.7%
2019$5.3345.84%
2018$3.669.72%
2017$3.33-9.54%
2016$3.6816.28%
2015$3.17184.1%
2014$1.11-57.15%
2013$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.60-16.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.71 0.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.18 81.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.99 213.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.67-45.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.72-59.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.06-84.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.91 18.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.61-75.95%๐Ÿ‡บ๐Ÿ‡ธ USA